Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race.

Publication/Presentation Date

6-1-2022

Abstract

BACKGROUND: Socioeconomic and health care utilization factors are major drivers of prostate cancer (PC) mortality disparities in the USA; however, tumor molecular heterogeneity may also contribute to the higher mortality among Black men.

OBJECTIVE: To compare differences in PC subtype frequency and genomic aggressiveness by self-identified race.

DESIGN SETTING AND PARTICIPANTS: Five molecular subtype classifiers were applied for 426 Black and 762 White PC patients in the Decipher Genomics Resource Information Database (GRID).

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Differences in subtype frequency and tumor genomic risk (Decipher score >0.6) by race were evaluated using χ

RESULTS AND LIMITATIONS: Subtype frequencies differed by race for four classifiers. Subtypes characterized by the presence of

CONCLUSIONS: The frequency of PC molecular subtypes differed by self-identified race. Additional studies are required to evaluate whether our observations suggest differences in the tumor genomic risk of progression by self-identified race.

PATIENT SUMMARY: We studied five classifiers that identify subtypes of prostate tumors and found that subtypes differed in frequency between Black and White patients. Further research is warranted to evaluate how differences in tumor subtypes may contribute to disparities in prostate cancer mortality.

Volume

40

First Page

19

Last Page

26

ISSN

2666-1683

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

35638091

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS